Publications
5674 Results
- Journal / Conference
- Cancer Treat Rep 67:739-740
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7961
Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease (HD): A Southwest Oncology Group Phase II study
- Journal / Conference
- Investigational New Drugs 1:065-070
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8005
Mitoxantrone hydrochloride (NSC-301739) in lymphoma. A Southwest Oncology Group study
- Journal / Conference
- In: 13th International Congress of Chemotherapy (Vienna, August 28-Sepember 2, 1983). KH Spitzy, K Karrer, eds. Symposium Mitoxantrone 212:52-55
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8005
Mitoxantrone hydrochloride in lymphoma
- Journal / Conference
- In: 3rd NCI-EORTC Symposium on New Drugs in Cancer Therapy (Brussels, October 15-17, 1981) M Rozencweig, DD Von Hoff, MJ Staquet, eds. New Anticancer Drugs: Mitoxantrone and Bisantrene. New York: Raven Press 115-124.
- Year
- 1983
- Research Committee(s)
- Leukemia and Lymphoma
- Study Number(s)
- SWOG-8005, SWOG-8032
Mitoxantrone hydrochloride in hematologic malignancies: Southwest Oncology Group Phase II studies.
- Journal / Conference
- American Society of Hematology poster presentation, December
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7713/14
Prevention of central nervous system relapse in unfavorable histology non-Hodgkin's lymphoma. A Southwest Oncology Group study
- Journal / Conference
- Blood 62 (Suppl 1):212a (753)
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7713/14
Prevention of CNS relapse in unfavorable histology non-Hodgkin's lymphoma
- Journal / Conference
- ASCO #C-843
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7808
Correlation of clinical and biopsy determination of liver involvement in Stage III and IV Hodgkin's disease: A Southwest Oncology Group (SWOG) study
- Journal / Conference
- ASCO #C-818
- Year
- 1983
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7967
Vindesine, BCNU, Adriamycin and Prednisone (EBAP) in malignant lymphoma. For the Southwest Oncology Group (SWOG)
- Journal / Conference
- ASCO, #C-881
- Year
- 1983
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8065
Phase II trial of Dihydroxyanthracenedione in advanced malignant melanoma: A Southwest Oncology Group study.
- Journal / Conference
- J Clin Oncol 1:453-461
- Year
- 1983
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-7704/05